Tegaserod was withdrawn from the U.S. market on March 30, 2007. This
medication may still be used in limited emergency situations.
Tegaserod increases the action of a chemical called serotonin in the intestines. This
speeds the movement of stools through the bowels.
Tegaserod is used to treat severe, chronic, irritable bowel syndrome (IBS) in women who
have constipation (and not diarrhea) as their main bowel problem.
Tegaserod is also used to treat chronic constipation in patients younger than 55 years old.
Tegaserod may also be used for other purposes not listed in this medication guide.